Home Novo Nordisk Inc. (NNI) Products  >  Rare Endocrine Disorder Products

Novo Nordisk Inc. (NNI) Products

Novo Nordisk has multiple products on the market for the treatment of Diabetes, Obesity, Growth Hormone Disorders, Hemophilia and Rare Bleeding Disorders. Access information and resources on each of our products below.

Explore Products

Rare Endocrine Disorders

Norditropin®

(somatropin) injection 5 mg, 10 mg, 15 mg, 30 mg pens

Norditropin® (somatropin) injection is a recombinant human growth indicated for treatment of pediatric patients with growth failure due to inadequate secretion of endogenous growth hormone (GH), short stature associated with Noonan Syndrome, short stature associated with Turner syndrome, short stature born small for gestational age (SGA) with no catch-up growth by age 2 to 4 years, Idiopathic Short Stature (ISS), and growth failure due to Prader-Willi Syndrome and replacement of endogenous GH in adults with growth hormone deficiency.

Prescribing Information

Sogroya®

(somapacatin-beco) injection 5 mg/1.5 mL (3.3mg/mL)

Sogroya® (somapacitan-beco) injection is a human growth hormone analog indicated for replacement of endogenous growth hormone in adults with growth hormone deficiency.

Prescribing Information

Vagifem®

estradiol vaginal inserts

Vagifem® (estradiol vaginal inserts) is an estrogen indicated for the treatment of atrophic vaginitis due to menopause.

Prescribing Information
Rare Endocrine Disorders icon in white

rare
endocrine
disorders

Explore
Novo Nordisk® Scientific Exchange logo

Scientific Exchange is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.

This medical content was developed independently by a third party via an educational grant. This material is copyright protected and is provided here with permission for educational and informational purposes only and is not certified for continuing education credits.

Continue

You are now leaving the Novo Nordisk Scientific Exchange website.

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.

Continue

GATED INTERSTITAL  

You are now leaving the Novo Nordisk Scientific Exchange website.

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.

ACCESS DENIED

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.